Does Beladev Shavit’s Form 3 for Kamada (KMDA) show any recent share purchases or sales?

The Form 3 does not report explicit buy or sell transactions . It mainly lists Shavit’s existing holdings in Ordinary Shares and option awards, serving as an initial ownership statement rather than documenting recent trading activity in Kamada stock.

Kamada (KMDA) VP Shavit reports ordinary shares and option grants

Q: What does Beladev Shavit’s Form 3 show for Kamada (KMDA)?

The Form 3 shows that VP Plasma Operations Beladev Shavit reports initial ownership in Kamada . He holds 3,418 Ordinary Shares directly plus multiple option grants to purchase additional Ordinary Shares at specified exercise prices and expiration dates.

Q: How many Kamada (KMDA) ordinary shares does Beladev Shavit directly hold?

Beladev Shavit directly holds 3,418 Ordinary Shares of Kamada. This reflects his current direct equity position separate from options, which give him the right to acquire additional Ordinary Shares in the future at preset exercise prices.

Q: How are Beladev Shavit’s Kamada (KMDA) options exercisable?

The options to purchase Kamada Ordinary Shares are exercisable using a net-exercise method . Under net exercise, the holder receives fewer shares instead of paying cash, with some shares effectively used to cover the exercise cost and related obligations.

Q: How were Kamada (KMDA) option exercise prices translated into U.S. dollars?

All option exercise prices presented in U.S. dollars are convenience translations from NIS . They are based on the Bank of Israel’s representative exchange rate as of March 13, 2026, providing investors with a consistent dollar-denominated reference.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kamada Ltd executive Beladev Shavit, VP Plasma Operations, has filed an initial ownership report. Shavit directly holds 3,418 Ordinary Shares and several option grants to purchase additional Ordinary Shares at exercise prices of $6.15 and $7.55, with expirations between 2028 and 2035. These options are exercisable using a net-exercise method, and the U.S. dollar exercise prices reflect translation from NIS based on the Bank of Israel’s representative exchange rate as of March 13, 2026.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Beladev Shavit

Role VP Plasma Operations

Type	Security	Shares	Price	Value
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options to purchase Ordinary Shares — 15,000 shares (Direct); Ordinary Shares — 3,418 shares (Direct)

Footnotes (1)

These options to purchase ordinary shares are exercisable using a net-exercise method All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

Understanding Insider Trading Forms →

03/16/2026 - 07:07 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Beladev Shavit

(Last)

(First)

(Middle)

15 GEFEN ST.

(Street)

MEITAR

8502500

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP Plasma Operations

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,418	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to purchase Ordinary Shares⁽¹⁾	02/28/2026	08/28/2028	Ordinary Shares	15,000	$6.15⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2026	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2027	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2028	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2029	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Shavit Beladev	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What does Beladev Shavit’s Form 3 show for Kamada (KMDA)?

The Form 3 shows that VP Plasma Operations Beladev Shavit reports initial ownership in Kamada. He holds 3,418 Ordinary Shares directly plus multiple option grants to purchase additional Ordinary Shares at specified exercise prices and expiration dates.

How many Kamada (KMDA) ordinary shares does Beladev Shavit directly hold?

Beladev Shavit directly holds 3,418 Ordinary Shares of Kamada. This reflects his current direct equity position separate from options, which give him the right to acquire additional Ordinary Shares in the future at preset exercise prices.

What stock options are reported for Beladev Shavit in Kamada (KMDA)?

Shavit reports several option grants to purchase Ordinary Shares, including options with a $6.15 exercise price expiring in 2028 and additional grants with a $7.55 exercise price expiring in 2035. Each grant covers 15,000 underlying Ordinary Shares.

How are Beladev Shavit’s Kamada (KMDA) options exercisable?

The options to purchase Kamada Ordinary Shares are exercisable using a net-exercise method. Under net exercise, the holder receives fewer shares instead of paying cash, with some shares effectively used to cover the exercise cost and related obligations.

How were Kamada (KMDA) option exercise prices translated into U.S. dollars?

All option exercise prices presented in U.S. dollars are convenience translations from NIS. They are based on the Bank of Israel’s representative exchange rate as of March 13, 2026, providing investors with a consistent dollar-denominated reference.